Reading between the Lines of 4 Marijuana Penny Stocks: Nuvilex Inc. (OTCQB - NVLX), FusionPharm Inc. (OTCPINK: FSPM), Growlife Inc. (OTCBB: PHOT), Hemp Inc. (OTCPINK: HEMP)

Publishing & Media

Share Tweet

Reading between the Lines of 4 Marijuana Penny Stocks: Nuvilex Inc. (OTCQB - NVLX), FusionPharm Inc. (OTCPINK: FSPM), Growlife Inc. (OTCBB: PHOT), Hemp Inc. (OTCPINK: HEMP)

As the frenzy being triggered by the astronomical potential of the legal-marijuana industry reaches a fever’s pitch, so does the hype coming from marijuana penny stocks.

In the interest of trying to encourage cooler heads among investors, here are four penny stocks where you should carefully read behind the lines of their super-positive news releases.

High Stock Volume

Nuvilex Inc. (OTCQB - NVLX) stock volume soared to 6,285,007 shares Jan. 31, nearly double its three-month average of 3,562,077 shares.

The uptick in volume is probably being fueled by a spate of good news being churned out by the Silver Spring-Md.-based biotechnology company that is developing new cancer and diabetes treatments from cannabis.

New Technology Acquired

On Jan. 30, Nuvilex announced it had acquired a 14.5% equity interest in Austrianova Singapore Pte. Ltd. This fulfils an obligation by Austrianova to Nuvilex that was part of the asset purchase agreement between both companies pertaining to the acquisition of Bio Blue Bird AG and, with it, the worldwide exclusive rights for Nuvilex to use Austrianova's Cell-in-a-Box cellulose-based live-cell encapsulation technology for the development of treatments for all types of cancer. Nuvilex has also obtained from Austrianova Singapore the exclusive worldwide rights to use the Cell-in-a-Box technology for the development of treatments for diabetes.

This news comes only three days after another release by Nuvilex talked in glowing terms about its foray into the medical-marijuana business.

According to the Jan. 27 release, Nuvilex is entering the legal-marijuana market via its wholly-owned subsidiary Medical Marijuana Sciences.  In the release, Nuvilex vowed to build a company that will be capable of competing with any other company in the sector.  The release also touted Dr. Mark Rabe as a well-known figure in the medical marijuana industry, who it named as chairman of the Scientific Advisory Board for Medical Marijuana Sciences. No specific business plans or deals were mentioned. 


Reading between the Lines

Nuvilex has high hopes, ambitions and plans. However, so far, it has only begun positioning itself to begin seeking approval for cannabis-related treatments that may or may not be approved anytime soon.

On Jan. 31, 2014, shares of NVLX closed at 0.1844 cents, up 0.0034 cents from 0.181, the previous day’s close.

Find out what could be the best investor’s move when it comes to NVLX by getting the complete report here, or by cutting and pasting the following link in your Web browser:


Commerce City, Colo-based FusionPharm Inc. (OTCPINK: FSPM) makes and sells cultivation containers for marijuana growers.

Share Value Increases 36% Jan. 31

It’s a down-to-earth business with much growth potential. On Jan. 31, its stock volume continues to soar, with 1,550,988 shares changing hands, nearly six times its three-month average of 258,830 shares.

Its robust volume and the nice 36% increase in its share value at the close of the market Jan. 31 were most probably being pushed by FusionPharm’s announcement that it posted a 38% revenue growth, quarter to quarter, for the period ended Sept. 30, 2013. In a written statement, FusionPharm said it anticipates posting its year-end results before the end of February, 2014.

"Our third quarter results are but an indicator of things to come" CEO Scott Dittman said, in a written statement. "We have completed our retrofit of our new Denver manufacturing and sales facility and are busily filling orders bound for customers in both the United States and Canada. We couldn't be more excited about the future," he added.

Reading between the Lines

While 38% revenue sounds impressive, the obvious question any potential investor would have is: 38% or what?  Unfortunately, we won’t know any numbers until FusionPharm releases them by end of February. Still, the company’s cultivation containers are practical and if they work as advertised, they could become a big hit among cannabis growers. But it is too early to tell. We won’t know that until FusionPharm shares with the public how many orders it has actually taken.

On Jan. 31, FSPM’s share price closed at $6.76, up $1.78 from its closing price of $4.98 the previous day.

 Find out what could be the best investor’s move when it comes to FSPM by getting the complete report here, or by cutting and pasting the following link in your Web browser:


Hydroponic Grow Containers

Another marijuana penny stock with a soaring stock volume is Growlife Inc. (OTCBB: PHOT), a Woodland Hills, Calif. holding company operating in the legal cannabis industry. On Jan. 31, the company’s share volume hit 63,463,862, which is more than double its three-month daily average of 33,181,709.  PHOT shares closed at 31 cents, up 3 cents from its closing price of 28 cents the previous day.

Growlife is strongly positioning itself by developing various markets and deploying new products and services for the legal cannabis industry. For example, one of its recently acquired companies makes hydroponic grow containers, which are designed to grow vegetables, herbs, flowers and fruits in any environment.  The company appears to be vigorously considering every possible angle and service to capture its piece of the legal cannabis pie.

On Jan. 31, Growlife announced that it had entered into a strategic partnership with RXNB Inc.  Growlife entered into an agreement to purchase a 40% equity stake in RXNB Inc. To sell and distribute RXNB proprietary technologies globally and share profits related to technology licensing, subject to the approval of the GrowLife board. GrowLife currently has a 45% ownership interest in OGI, with conditions under which it can gain majority interest.

The release further explains that RXNB is an investment company with holdings in drug formulation, manufacturing, and distribution. The company represents a recent roll-up of several independent companies in the pharmaceutical and nutraceutical market. RXNB has numerous pending patents in the field of THC research and development. RXNB has a portfolio valuation of $110 million dollars and approximately $27.5 million dollars in annual revenue.

Reading between the Lines

While this certainly seems like a strong positioning move by Growlife, and it’s nice to know that the company it has just acquired a 40% equity share in has revenue of 27.5 million, we don’t have any idea if the company has earned any profits. So again, we must wait for more thorough info before getting too excited about Growlife’s latest moves.

Find out what could be the best investor’s move when it comes to PHOT by getting the complete report here, or by cutting and pasting the following link in your Web browser:

Developing Vaporizer Products

Hemp Inc. (OTCPINK: HEMP) is a Las Vegas-based company that is developing a variety of products made from industrial hemp. They include fabric, paper, insulation, plastics, cooking oil and even salad dressings.

Developing Vaporizer Products

On Jan. 28, VaporBrands International, Inc. (OTC Pink: VAPR) announced it has entered into a Letter of Intent to form a joint venture with Marijuana, Inc. (a wholly owned subsidiary of Hemp.

Under terms of the proposed joint venture, Marijuana, Inc. will assist VaporBrands with the development and distribution of specialized marijuana vaporizing products to be sold primarily through existing medical marijuana dispensary networks.

In addition, VaporBrands and Marijuana, Inc. have agreed to research, develop and distribute vaporizer products specifically for the use of Hemp Oil in natural medicine. Marijuana, Inc. has also agreed to assist VaporBrands in expanding the retail distribution of its current and future electronic nicotine based cigarette products.

Reading between the Lines

This latest move by HEMP through its subsidiary certainly strengthens its position in the marketplace. It also filled a much needed gap in its vertical offerings. While it’s too soon to measure how this will affect HEMP’s overall revenue, it is a positive move.

 Jan. 31, HEMP closed at 9 cents, up 1 cent from yesterday’s close of 8 cents.

Find out what could be the best investor’s move when it comes to HEMP by getting the complete report here, or by cutting and pasting the following link in your Web browser:

ABOUT US: issues momentum alerts on stocks that can provide gains to day traders. provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more.  monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Gain an Edge by joining the newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here:

Disclosure is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always own due diligence with any potential investment. Please visit website, for complete risks and disclosures.

conduct their Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.